ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Hot Features

Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.

ZVRA Zevra Therapeutics Inc

4,55
-0,10 (-2,15%)
17 Jun 2024 - Fechado
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
Zevra Therapeutics Inc ZVRA NASDAQ Ordinária
  Variação do Dia (p) Variação do Dia % Último Preço Hora
-0,10 -2,15% 4,55 18:13:22
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
4,65 4,535 4,70 4,55 4,65
mais cotações »

Notícias Recentes

Data Hora Fonte Título
03/06/202412:00GLOBEZevra Therapeutics Announces Positive Final Results from..
09/05/202408:30GLOBEZevra Therapeutics to Participate at Upcoming Investor..
08/05/202408:00GLOBEZevra Therapeutics Reports First Quarter 2024 Financial..
01/05/202408:30GLOBEZevra Therapeutics to Report First Quarter 2024 Results on..
29/04/202408:30GLOBEZevra Therapeutics’ President and Chief Executive Officer..
15/04/202418:01GLOBEZevra Therapeutics Presents New Data on the Long-Term Safety..
10/04/202408:30GLOBEZevra Therapeutics Refinances Existing Debt with up to $100M..
28/03/202417:32GLOBEZevra Therapeutics Reports Fourth Quarter and Full Year 2023..
28/03/202408:42IHMARKETNEWSUS Stock Futures Stable in Pre-Market On Path for..
26/03/202417:30GLOBEZevra Therapeutics Announces Top-Line Data from the Phase 2..
25/03/202417:30GLOBEZevra Therapeutics to Present at the 23rd Annual Needham..
18/03/202408:30GLOBEZevra Therapeutics to Report 2023 Fourth Quarter and Full..
04/03/202409:30GLOBEZevra Therapeutics Provides FDA Update on the PDUFA Action..
28/02/202409:30GLOBEZevra Therapeutics to Participate at Upcoming Investor..
06/02/202409:30GLOBEZevra Therapeutics to Present at the Oppenheimer 34th Annual..
23/01/202409:30GLOBEZevra Therapeutics Appoints Experienced Biopharma Executive..
11/01/202418:50DJNXoma to Make $1 Million Milestone Payment to LadRx After FDA..
08/01/202409:30GLOBEZevra Therapeutics Receives FDA Acceptance of Resubmission..
04/01/202410:55GLOBEZevra Therapeutics Appoints Global Medical Leader, Adrian..
27/12/202310:24DJNZevra Therapeutics Refiles Arimoclomol Application With FDA
27/12/202309:30GLOBEZevra Therapeutics Announces Resubmission of Arimoclomol New..
20/11/202309:30GLOBEZevra Therapeutics Completes Acquisition of Acer..
07/11/202309:00GLOBEZevra Therapeutics Reports Corporate Updates and Third..
31/10/202308:30GLOBEZevra Therapeutics to Report Third Quarter 2023 Results on..
19/10/202308:30GLOBEZevra Therapeutics Celebrates and Supports Global..
10/10/202308:30GLOBEZevra Therapeutics Appoints Neil F. McFarlane as President,..
05/10/202308:30GLOBEZevra Therapeutics to Present at the 52nd Child Neurology..
02/10/202308:30GLOBEZevra Therapeutics Announces Interim Data from the Phase 2..
20/09/202308:30GLOBEZevra Therapeutics to Participate in the Cantor Global..
09/09/202321:00GLOBEZevra Therapeutics Presents Full Data Set on the..
05/09/202308:30GLOBEZevra Therapeutics to Participate in the H.C. Wainwright..
31/08/202308:30GLOBEZevra Therapeutics to Acquire Acer Therapeutics, Expanding..
14/08/202308:30GLOBEZevra Therapeutics Reports Corporate Updates and Second..
07/08/202317:45GLOBEZevra Therapeutics Appoints Thomas Anderson to Board of..
02/08/202308:30GLOBEZevra Therapeutics to Report Second Quarter 2023 Results on..
19/07/202308:30GLOBEZevra Therapeutics to Participate in the 2023 NNPDF Family..
20/06/202308:30GLOBEZevra Therapeutics to be Added to Russell 2000® and Russell..

Seu Histórico Recente

Delayed Upgrade Clock